| Bioactivity | C14 Ceramide (d18:1/14:0) is an endogenous ceramide produced by ceramide synthetase 6, which can be used for Parkinson's and diabetes research[1][2]. |
| CAS | 123408-74-2 |
| Formula | C32H63NO3 |
| Molar Mass | 509.85 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Oertel S, et al. Ceramide synthase 2 deficiency aggravates AOM-DSS-induced colitis in mice: role of colon barrier integrity. Cell Mol Life Sci. 2017 Aug;74(16):3039-3055. [2]. Choi S, et al. Myristate-induced endoplasmic reticulum stress requires ceramide synthases 5/6 and generation of C14-ceramide in intestinal epithelial cells. FASEB J. 2018 Oct;32(10):5724-5736. |
C14 Ceramide (d18:1/14:0)
CAS: 123408-74-2 F: C32H63NO3 W: 509.85
C14 Ceramide (d18:1/14:0) is an endogenous ceramide produced by ceramide synthetase 6, which can be used for Parkinson's
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.